Key Takeaways
- Target’s fiscal Q2 FY26 results arrive August 19, with options traders anticipating a 7.08% price movement
- Shares have surged 59% in 2025, reaching $155.51, yet Bank of America maintains an Underperform stance with a $124 target
- BofA’s updated Q2 earnings-per-share projection stands at $2.34 (up 3%), expecting comparable sales to climb 2.5% and gross margins to widen by approximately 90 basis points
- Analyst consensus calls for Q2 EPS of $2.32, reflecting 13.2% annual growth, alongside revenue of $26.12 billion (up 3.6%)
- Analyst sentiment leans Moderate Buy with 12 positive, 15 neutral, and 2 negative ratings; the $143.15 average target suggests potential 8% decline
As Target prepares to unveil its second fiscal quarter performance on August 19, the retail giant finds itself at a crossroads. Shares concluded Thursday’s session at $155.51, gaining approximately 1% and extending the year’s remarkable 59% advance.
Derivatives pricing suggests investors should prepare for volatilityāthe options chain indicates a potential 7.08% movement following the announcement. This translates to approximately an $11 shift, establishing an upside zone around $166.52 and a downside boundary near $144.50.
Historical context reveals that Target‘s prior four earnings releases produced an average absolute movement of 4.93%, positioning the current implied volatility above typical patterns.
Street estimates point toward quarterly earnings of $2.32 per share, marking a 13.2% increase from the previous year. Revenue projections call for $26.12 billion, representing 3.6% growth.
Bank of America Maintains Caution Despite Upgraded Forecasts
Bank of America’s Chris Nardone recently adjusted his Q2 earnings forecast upward by 3% to $2.34 per share, while boosting the full-year projection to $8.84. His comparable sales growth estimate of 2.5% for the quarter edges past the Street’s 2.3% expectation.
Regarding profitability metrics, BofA anticipates gross margin improvement of roughly 90 basis points, exceeding consensus by approximately 20 basis points. This would continue the momentum from Q1, when gross margins expanded to 29% versus 28.2% in the prior year.
However, these optimistic figures haven’t swayed Nardone’s cautious stance. He retained his Underperform designation while adjusting the price objective to $124 from $110. Against the $155.51 trading level at publication, this target indicates potential downside of roughly 19%.
The firm’s hesitation stems from valuation concerns. Target currently commands approximately 17 times fiscal 2027 earnings projections, elevated from the 14-times multiple observed post-Q1. BofA’s valuation framework applies a 14-times multiple, which they characterize as consistent with the retailer’s historical trading patterns.
Wolfe Research Presents Contrasting Perspective
The bearish narrative doesn’t resonate universally. Wolfe Research‘s Spencer Hanus elevated his price objective to $169 from $162 while reaffirming a Buy recommendation. Hanus increased his same-store sales growth projection to 3%, pointing to strengthening momentum in Target’s operational turnaround.
His analysis anticipates gross margin performance exceeding expectations, while suggesting that any post-earnings pullback driven by short-term positioning could present an attractive entry point for investors focused on second-half catalysts.
Target’s commitment to its transformation is reflected in substantial financial commitments. The retailer has allocated approximately $1 billion in additional operating investments for 2025, dedicated to store staffing and employee development. Capital expenditure plans have expanded by over $1 billion to approximately $5 billion, funding new locations, store renovations, and distribution infrastructure.
BofA highlighted selling, general, and administrative expenses as an area of uncertainty. Target’s adjusted SG&A rate during Q1 increased to 21.9% from 21.7% year-over-year.
The broader Wall Street view reflects a Moderate Buy consensus, incorporating 12 bullish ratings, 15 neutral positions, and 2 sell recommendations. The $143.15 average price target suggests approximately 8% downside from present trading levels.


